**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 2001-95-8 |Valinomycin | 96% | 217-896-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T+
Risk Phrases: 27/28
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Very toxic in contact with skin and if swallowed.Highly toxic.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be fatal if absorbed through the
skin.
Ingestion:
May be fatal if swallowed. May cause irritation of the digestive
tract. May cause cardiac disturbances. May cause central nervous
system depression.
Inhalation:
May cause respiratory tract irritation. May cause cardiac
abnormalities. Inhalation at high concentrations may cause CNS
depression and asphixiation.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. SPEEDY ACTION IS CRITICAL!
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. SPEED IS ESSENTIAL. A DOCTOR MUST BE NOTIFIED AT
ONCE. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode when heated. Non-combustible, substance itself does not
burn but may decompose upon heating to produce irritating, corrosive
and/or toxic fumes.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Poison room
locked/refrigerator.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 2001-95-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 187.00 - 189.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: practically insoluble
Specific Gravity/Density:
Molecular Formula: C54H90N6O18
Molecular Weight: 1111.35
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 2001-95-8: YV9468000
LD50/LC50:
CAS# 2001-95-8: Oral, mouse: LD50 = 2500 ug/kg; Oral, rat: LD50 = 4
mg/kg; Skin, rabbit: LD50 = 5 mg/kg.
Carcinogenicity:
Valinomycin -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: I
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: I
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: I
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T+
Risk Phrases:
R 27/28 Very toxic in contact with skin and if
swallowed.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2001-95-8: 3
Canada
CAS# 2001-95-8 is listed on Canada's NDSL List.
CAS# 2001-95-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2001-95-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,6-Pyridinedicarboxylic Acid Chloride, 97%
| 3739-94-4 |
|
OPD tablets, 120 mg/tablet
| 615-28-1 |
|
Tetrabutylphosphonium bromide, 98%
| 3115-68-2 |
|
2'-Deoxyguanosine 5'-Monophosphate, Sodium Salt Hydrate
| 52558-16-4 |
|
4-(Dimethylamino)pyridinium Bromide Perbromide
| 92976-81-3 |
|
Mercury(ii) thiocyanate, p.a.
| 592-85-8 |
|
Beta-Ionone, Synthetic, 96%
| 14901-07-6 |
|
Quercetin (Pract)
| 117-39-5 |
|
4-Chlorobenzotrichloride, 99%
| 5216-25-1 |
|
1-Iodopropane, 99%, Stabilized over Copper
| 107-08-4 |
|
2-Acetyl-1-methylpyrrole, 99%
| 932-16-1 |
|
4-Dimethylamino-4'-nitrostilbene
| 4584-57-0 |
|
Pentafluorothiophenol, 97%
| 771-62-0 |
|
1-(4-METHOXYPHENYL)-1-CYCLOPROPANE- CARBONITRILE
| 16728-00-0 |
|
Triphenylthioantimonate, 99%
| 28609-58-7 |
|
4-Methylthiazole, 99%
| 693-95-8 |
|
DL-2-Amino-1-Propanol, 98%
| 6168-72-5 |
|
2,5-Diphenyl-p-benzoquinone (pract), 93% (uv-vis)
| 844-51-9 |
|
4-Methylbenzyltriphenylphosphonium chloride, 99%
| 1530-37-6 |
|
L-(+)-Prolinol
| 23356-96-9 |
|
Prostaglandin VIII, 99%
| 0-01-1 |
|
Allyl alcohol
| 107-18-6 |
|
Phosphorus Tribromide, 99%
| 7789-60-8 |
|
5-Nitroisoquinoline, 98%
| 607-32-9 |
|
1,3-Acetonedicarboxylic acid, 96%
| 542-05-2 |
|
Pentacene, 98%
| 135-48-8 |
|
3,3'-Dimethoxybenzidine dihydrochloride, 99% (titr.)
| 20325-40-0 |
|
Diethyl Bis(hydroxymethyl)malonate, 95% (HPLC)
| 20605-01-0 |
|
P-Bromo-DL-Phenylalanine, 99%
| 14091-15-7 |
|
1,2-(Didodecyloxy)benzene, 98% (GC)
| 42244-53-1 |
|
p-Anisaldehyde, 99+%
| 123-11-5 |
|
Diazogen, 99%
| 80-11-5 |
|
2-Fluoro-4-Nitrotoluene, 98%
| 1427-07-2 |
|
Sodium triacetoxyborohydride
| 56553-60-7 |
|
Indole-2-carboxylic acid, 99%
| 1477-50-5 |
|
Pyridoxine Hydrochloride, 99% (Titr.)
| 58-56-0 |
|
2,6-Dichlorophenol
| 87-65-0 |
|
1,2-Butanediol, 98%
| 26171-83-5 |
|
2-(2-Aminoethoxy)ethanol, 98%
| 929-06-6 |
|
Poly(propylene Glycol), Average M.W. 425
| 25322-69-4 |
|
Valinomycin, 96% (HPLC)
| 2001-95-8 |
|
7-Amino-4-Methyl-1,8-Naphthyridin-2-ol, 98 %
| 1569-15-9 |
|
Benzyl butyrate, 98%
| 103-37-7 |
|
Lutetium oxide, 99.99%, -325 mesh
| 12032-20-1 |
|
P-Nitrophenyl Chloroformate, 96% (Titr.)
| 7693-46-1 |
|
Potassium sorbate, 99%
| 590-00-1 |
|
Phthalan, 97%
| 496-14-0 |
|
Cinnamyl Acetate, 99+%
| 103-54-8 |
|
Butyl Isocyanatoacetate, 98% (GC)
| 17046-22-9 |
|
Zirconyl(IV) chloride octahydrate, 98+%
| 7699-43-6 |
|
|